LITTLE KNOWN FACTS ABOUT WHAT ARE THE BEST NEUROPROTECTIVE DRUGS?.

Dependant on the subgroup analysis, we found that there was important heterogeneity concerning mortality, favorable outcomes, and the full remedy productive level. Pertaining to mortality, The main reason for heterogeneity around the subgroup of edaravone dexborneol and EDV was generally attributed to variances in drug dosage. Pertaining to favorab